3135.0 The Future of Genomics in Public Health

Monday, October 29, 2012: 10:30 AM - 12:00 PM
Genomics contributes to all the conditions considered public health priorities. Although there are currently evidence-based recommendations for genetic testing and related management, their implementation has been slow. To determine how best to take advantage of genomic technologies at a population level, it is critical that we facilitate the implementation and dissemination of current knowledge and plan for the development of data to best inform public health moving forward. Speakers in this session will discuss successful approaches to implementation of those guidelines, the utility of pharmacogenomics in determining the most effective and cost effective population level treatment strategies, and priorities for the future of public health genomics.
Session Objectives: Describe current efforts and future directions in implementing, disseminating, and prioritizing genomics initiatives.

Public Health Action in Genomics is Now Needed Beyond Newborn Screening
Karen Greendale, MA, CGC, Scott Bowen, MPH, Muin Khoury, MD, PhD, William Dotson, PhD, Katherine Kolor, PhD, MS, Renee Ned, PhD, MMSc and Marta Gwinn, MD, MPH
Feasibility of using population level genomic knowledge for public health purchasing
Laura Panattoni, PhD, Paul Brown, PhD and Howard McLeod, PharmD
Priorities for public health genomics 2012-2017: A stakeholder consultation
Toby Citrin, JD, Stephen M. Modell, MD, MS and James O'Leary, BS

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Genomics Forum

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH) , Masters Certified Health Education Specialist (MCHES)

See more of: Genomics Forum